Last reviewed · How we verify

differin — Competitive Intelligence Brief

differin (differin) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Dermatology.

marketed Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

differin (differin) — University of Magdeburg.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
differin TARGET differin University of Magdeburg marketed Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha
Adapalen Adapalen Technische Universität Dresden marketed Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). differin — Competitive Intelligence Brief. https://druglandscape.com/ci/differin. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: